SCHEMBL9836660

SCHEMBL9836660

CCOC(=O)c1cn(C)c2cc(-c3ccccc3)sc2c1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.55
MAPT P10636 9/20 0.55
HPGD P15428 7/20 0.55
RAB9A P51151 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
HSD17B10 Q99714 3/20 0.55
GAA P10253 3/20 0.55
ALOX15 P16050 2/20 0.55
LMNA P02545 3/20 0.50
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
KDM4E B2RXH2 2/20 0.49
NPC1 O15118 2/20 0.49
TP53 P04637 2/20 0.48
THRB P10828 1/20 0.48
GSTO1 P78417 1/20 0.47
NPSR1 Q6W5P4 3/20 0.47
BAZ2B Q9UIF8 1/20 0.46
BAZ2A Q9UIF9 1/20 0.46
CNR2 P34972 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9837257 0.84 ALDH1A1 (0.46) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL9837349 0.82 IKBKB (0.49) ALDH1A1HPGDGAAMEN1KMT2A
SCHEMBL9837365 0.82 BAZ2B (0.53) ALDH1A1MAPTHPGDSMN1; SMN2HSD17B10
SCHEMBL9835705 0.80 BAZ2B (0.54) ALDH1A1MAPTHPGDHSD17B10GAA
SCHEMBL6479967 0.79 BAZ2B (0.47) ALDH1A1MAPTHPGDHSD17B10GAA
SCHEMBL6481160 0.79 BAZ2B (0.47) ALDH1A1MAPTHPGDHSD17B10GAA
SCHEMBL6050604 0.74 BAZ2B (0.47) ALDH1A1MAPTHPGDHSD17B10GAA
SCHEMBL15071685 0.74 ALDH1A1 (0.57) ALDH1A1MAPTHPGDRAB9AGAA
SCHEMBL976420 0.72 ALDH1A1 (0.72) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL10737753 0.72 NPC1 (0.41) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0269295-B1 THERAPEUTIC AGENTS The Boots Company PLC (GB) 1991-06-26 EP disclosed
US-4877793-A CARDIOVASCULAR DISORDERS THE BOOTS COMPANY, PLC (GB) 1989-10-31 US disclosed
EP-0269295-A1 Therapeutic agents The Boots Company PLC (GB) 1988-06-01 EP disclosed